Literature DB >> 24604582

The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails.

John F Thompson1, George Hruby.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24604582     DOI： 10.1245/s10434-014-3587-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

2.  Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143).

Authors:  Marco Rastrelli; Paolo Del Fiore; Irene Russo; Jacopo Tartaglia; Alessandro Dal Monico; Rocco Cappellesso; Lorenzo Nicolè; Luisa Piccin; Alessio Fabozzi; Bernardo Biffoli; Claudia Di Prata; Beatrice Ferrazzi; Luigi Dall'Olmo; Antonella Vecchiato; Romina Spina; Francesco Russano; Elisabetta Bezzon; Sara Cingarlini; Renzo Mazzarotto; Alessandro Parisi; Giovanni Scarzello; Jacopo Pigozzo; Tito Brambullo; Saveria Tropea; Vincenzo Vindigni; Franco Bassetto; Daniele Bertin; Michele Gregianin; Angelo Paolo Dei Tos; Francesco Cavallin; Mauro Alaibac; Vanna Chiarion-Sileni; Simone Mocellin
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

3.  Merkel cell carcinoma in immunosuppressed patients.

Authors:  Janice E Ma; Jerry D Brewer
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

4.  Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies.

Authors:  Mark S Swanson; Uttam K Sinha
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.